20th World Congress of Basic and Clinical Pharmacology
20th World Congress of
Basic and Clinical Pharmacology 2026
#WCP2026
Keynote speakers
More speakers will be announced over the coming weeks.
Professor Sharon Lewin
AO
Professor Sharon Lewin AO
Professor Sharon Lewin is the Director of the Peter Doherty Institute for Infection and Immunity, a joint venture between the University of Melbourne and Royal Melbourne Hospital; Director of the Cumming Global Centre for Pandemic Therapeutics; and Melbourne Laureate Professor at The University of Melbourne.
Sharon is an infectious diseases physician and basic scientist. Her research focuses on understanding why HIV persists on treatment and developing clinical trials aimed at ultimately finding a cure for HIV infection. Sharon is recognised as a leading global expert in HIV science. She has received numerous awards, including being appointed an Officer of the Order of Australia (AO) in recognition of her distinguished service to medical research, and to education and clinical care, in the field of infectious diseases, particularly HIV and AIDS.
Professor Csaba Szabo M.D., Ph.D., D.Sc., F.B.P.S.
Professor Szabo is a globally recognised expert in oxidative and nitrosative stress, gaseous transmitters, cell dysfunction, and inflammatory mechanisms. He pioneered the concept of identifying the nuclear enzyme PARP's role in promoting cell necrosis, contributing to critical illnesses and cardiovascular diseases. In the last decade, Szabo focused on hydrogen sulfide, discovering its roles in shock, angiogenesis, cancer, and Down syndrome, leading to new therapeutic concepts. His recent work has also explored cyanide's biological roles in mammals.
Trained as an M.D./Ph.D. in Budapest, Szabo worked as a postdoc with Nobel Laureate Sir John Vane in London. He then led multiple research groups across the USA in both academia and industry, and now chairs the Pharmacology Section and the Department of Oncology, Microbiology, and Immunology at the University of Fribourg (Switzerland). His work has led to clinical-stage drugs, significant transactions, the pioneering of novel pathophysiological and pharmacological concepts and tools. He is recognised as one of the world's most cited pharmacologists with a H-index of 150. He has received numerous prestigious awards and serves on a number of editorial boards.
